NCT06350110 Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) Status RECRUITING Phase PHASE1/PHASE2
NCT06342713 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases Status COMPLETED Phase PHASE1
NCT06318533 A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06291415 The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE1
NCT06279923 CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06243159 JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06235580 Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions Status RECRUITING Phase N/A
NCT06183190 Gut Microbiota In Children With Autoimmune Liver Disease and Its Effect on Treatment Response Status COMPLETED Phase N/A
NCT06069583 Implementation of Support in the Care of Adults Living With Type 1 Diabetes Status RECRUITING Phase NA
NCT06054373 The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases Status RECRUITING Phase N/A
NCT06035614 Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children Status COMPLETED Phase NA
NCT05974683 Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period Status NOT_YET_RECRUITING Phase NA